Literature DB >> 14662828

Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties.

William O'Connor1, Jonathan A Harton, Xinsheng Zhu, Michael W Linhoff, Jenny P-Y Ting.   

Abstract

Mutations in the cold-induced autoinflammatory syndrome 1 (CIAS1) gene have been recently linked to three chronic autoinflammatory disorders. These observations point to an important role for CIAS1 in regulating inflammatory processes. We report that TNF-alpha and ligands recognized by multiple Toll-like receptors rapidly induce CIAS1 gene expression in primary human monocytes. Transfection of full-length CIAS1 or either of two shorter, naturally occurring isoforms dramatically inhibited TNF-alpha-induced activation of NF-kappaB reporter activity. Furthermore, CIAS1 suppressed TNF-alpha-induced nuclear translocation of endogenous p65. Transcriptional activity of exogenous NF-kappaB p65 was also blocked by CIAS1. The nucleotide-binding and leucine-rich repeat regions, but not the pyrin domain of CIAS1, are responsible for this inhibition. These data suggest CIAS1/cryopyrin may act as a key regulator of inflammation, induced to dampen NF-kappaB-dependent proinflammatory signals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662828     DOI: 10.4049/jimmunol.171.12.6329

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

1.  Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation.

Authors:  Maninjay K Atianand; Ellen B Duffy; Aaloki Shah; Supriya Kar; Meenakshi Malik; Jonathan A Harton
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome.

Authors:  John M Busillo; Kathleen M Azzam; John A Cidlowski
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

3.  Post-transcriptional inhibition of luciferase reporter assays by the Nod-like receptor proteins NLRX1 and NLRC3.

Authors:  Arthur Ling; Fraser Soares; David O Croitoru; Ivan Tattoli; Leticia A M Carneiro; Michele Boniotto; Szilvia Benko; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

Review 4.  Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines.

Authors:  Brianne R Barker; Debra J Taxman; Jenny P-Y Ting
Journal:  Curr Opin Immunol       Date:  2011-08-10       Impact factor: 7.486

Review 5.  Molecular mechanisms regulating NLRP3 inflammasome activation.

Authors:  Eun-Kyeong Jo; Jin Kyung Kim; Dong-Min Shin; Chihiro Sasakawa
Journal:  Cell Mol Immunol       Date:  2015-11-09       Impact factor: 11.530

6.  The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency.

Authors:  Alessandra Pontillo; Elisa Paoluzzi; Sergio Crovella
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

Review 7.  Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation.

Authors:  L Ferrero-Miliani; O H Nielsen; P S Andersen; S E Girardin
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

8.  Internalization and phagosome escape required for Francisella to induce human monocyte IL-1beta processing and release.

Authors:  Mikhail A Gavrilin; Imad J Bouakl; Nina L Knatz; Michelle D Duncan; Mark W Hall; John S Gunn; Mark D Wewers
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

9.  Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain.

Authors:  Nicole B Bryan; Andrea Dorfleutner; Yon Rojanasakul; Christian Stehlik
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Curcumin: a double hit on malignant mesothelioma.

Authors:  Jill M Miller; Joyce K Thompson; Maximilian B MacPherson; Stacie L Beuschel; Catherine M Westbom; Mutlay Sayan; Arti Shukla
Journal:  Cancer Prev Res (Phila)       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.